Home Stock The South African regulator recommends a suspension of J&J vaccines after a...

The South African regulator recommends a suspension of J&J vaccines after a number of conditions


© Reuters. COVID-19 vaccination at Khayelitsha Hospital near Cape Town


(Reuters) – South Africa’s Health Regulatory Authority, on Saturday, recommended the government to lift the suspension of COVID-19 vaccine administration by pharmaceutical manufacturer Johnson & Johnson (NYSE :), with conditions meet certain conditions.

The South African Health Products Authority (SAHPRA) said: “These conditions include, but are not limited to, enhanced screening and monitoring of participants at high risk of clotting disorders. “.

“Additionally, measures will be taken to ensure the safe management of any participant who develops vaccine-induced thrombocytopenia and thrombocytopenia (VITT),” the statement added.

SAHPRA said on Wednesday that it had reviewed data from local Johnson & Johnson research on vaccination of health workers and found no major safety concerns.

South Africa suspended the implementation of J&J vaccines in the “development study” on Tuesday, after US health authorities recommended suspending the use of the vaccine because of rare cases. blood clots in six vaccinated people, out of about 7 million people shot in the United States.

A US council will meet next week to discuss whether the suspension of vaccines should continue, after delaying a vote on the matter earlier this week.

Disclaimer: Fusion Media wants to remind you that the data contained in this website is not necessarily real-time nor is it accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but are provided by the market makers, so the prices may be inaccurate and available. may differ from actual market price, which means that price is indicative only and not suitable for trading purposes. Consequently, Fusion Media accepts no liability whatsoever for any transaction losses you may incur as a result of using this data.

Fusion Media or anyone associated with Fusion Media will not be liable in any way for loss or damage resulting from dependence on information including data, quotes, charts and buy / sell signals contained in the this site. Please be fully informed about the risks and costs associated with trading the financial markets, which is one of the riskiest investments possible.



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments